Biodyne Corp. sold a patent to a pharmaceutical company for $2.5 million in 2020. The patent had a book value of $4 million on Biodyne's balance sheet at the time of the sale. Biodyne also had $6 million in cash sales, and $2 million in cash expenses during 2020. What is Biodyne's operating and investing cash flow in 2020?

Answer rating: 100% (QA)

To calculate Biodyne Corps operating and investing cash flow in 2020 we need to use the indirect met... View the full answer